Related Experiment Video
Updated: Jun 11, 2025

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
Challenging the Norm: The Unrecognized Impact of Soluble Guanylyl Cyclase Subunits in Cancer
María Teresa L Pino1, María Victoria Rocca1, Lucas H Acosta1
1Centro de Altos Estudios en Ciencias Humanas y de la Salud, CONICET-Universidad Abierta Interamericana, Buenos Aires C1270AAH, Argentina.
Abstract:
Since the discovery of nitric oxide (NO), a long journey has led us to the present, during which much knowledge has been gained about its pathway members and their roles in physiological and various pathophysiological conditions. Soluble guanylyl cyclase (sGC), the main NO receptor composed of the sGCα1 and sGCβ1 subunits, has been one of the central figures in this narrative. However, the sGCα1 and sGCβ1 subunits remained obscured by the focus on sGC's enzymatic activity for many years. In this review, we restore the significance of the sGCα1 and sGCβ1 subunits by compiling and analyzing available but previously overlooked information regarding their roles beyond enzymatic activity. We delve into the basics of sGC expression regulation, from its transcriptional regulation to its interaction with proteins, placing particular emphasis on evidence thus far demonstrating the actions of each sGC subunit in different tumor models. Exploring the roles of sGC subunits in cancer offers a valuable opportunity to enhance our understanding of tumor biology and discover new therapeutic avenues.
Insights
This review highlights the crucial roles of soluble guanylyl cyclase (sGC) subunits beyond their enzymatic activity, particularly in cancer. Understanding these sGC roles offers new therapeutic avenues.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Nitric oxide (NO) signaling is vital in physiology and disease.
- Soluble guanylyl cyclase (sGC), the primary NO receptor, comprises sGCα1 and sGCβ1 subunits.
- The functions of sGC subunits beyond enzymatic activity have been historically overlooked.
Purpose of the Study:
- To re-evaluate and emphasize the significance of sGCα1 and sGCβ1 subunits.
- To compile and analyze overlooked information on sGC subunit functions.
- To explore the roles of sGC subunits in various tumor models.
Main Methods:
- Literature review and analysis of existing data.
- Compilation of information on sGC expression regulation (transcriptional, protein interactions).
- Emphasis on evidence of sGC subunit actions in cancer models.
Main Results:
- sGC subunits have critical roles beyond NO-stimulated enzymatic activity.
- sGC expression is regulated at transcriptional and post-translational levels.
- Specific evidence demonstrates the actions of sGC subunits in different tumor types.
Conclusions:
- sGC subunits are key players in tumor biology.
- Investigating sGC subunit functions can reveal novel therapeutic targets in cancer.
- This review provides a foundation for future research into sGC-targeted cancer therapies.
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
GTPases and their Regulation
Large G-proteins,...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Mitogens and the Cell Cycle
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Positive Regulator Molecules

